Format

Send to

Choose Destination
See comment in PubMed Commons below
Haematologica. 1991 Sep-Oct;76(5):431-3.

Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.

Author information

  • 1A. Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ospedale Maggiore, Universit√† di Milano, Italy.

Abstract

The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when it occurs in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are two important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is one major clinical complication in women with these disease. We have studied three patients with this hemorrhagic complication. Our data show that oral contraceptives are an effective way to avoid hemoperitoneum.

PIP:

The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when occurring in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are 2 important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is 1 major clinical complication in women with these diseases. The authors examined 3 patients with this hemorrhagic complication and data show that oral contraceptives are an effective means to avoid hemoperitoneum.

PMID:
1806451
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center